{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:07:10Z","timestamp":1790482030847,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DST","award":["GAP0258"],"award-info":[{"award-number":["GAP0258"]}]},{"name":"CSIR network project, THUNDER","award":["BSC0102"],"award-info":[{"award-number":["BSC0102"]}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.yjmcc.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T16:17:23Z","timestamp":1534781843000},"page":"46-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice"],"prefix":"10.1016","volume":"123","author":[{"given":"Sukka Santosh","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Barthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.yjmcc.2018.08.017_bb0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.metabol.2015.07.014","article-title":"Increased expression of ATP-binding cassette transporter A1 (ABCA1) as a possible mechanism for the protective effect of cilostazol against hepatic steatosis","volume":"64","author":"Jeon","year":"2015","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/hepr.12140","article-title":"Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis","volume":"44","author":"Saito","year":"2014","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-013-0120-y","article-title":"Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event","volume":"47","author":"Huh","year":"2014","journal-title":"Endocrine"},{"issue":"1\u20133","key":"10.1016\/j.yjmcc.2018.08.017_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2013.03.016","article-title":"Cilostazol ameliorates systemic insulin resistance in diabetic db\/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions","volume":"707","author":"Wada","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.08.017_bb0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.109.154328","article-title":"Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats","volume":"330","author":"Sun","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000447769","article-title":"Cilostazol Prevents Atrial Structural Remodeling through the MEK\/ERK Pathway in a Canine Model of Atrial Tachycardia","volume":"135","author":"Zhao","year":"2016","journal-title":"Cardiology"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1139\/Y08-005","article-title":"Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction","volume":"86","author":"Sanganalmath","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2015.07.016","article-title":"Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice","volume":"89","author":"Koh","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/CMC.S11156","article-title":"Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography","volume":"7","author":"Kossaify","year":"2013","journal-title":"Clin. Med. Insights Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrcardio.2017.108","article-title":"Management of cardiovascular diseases in patients with obesity","volume":"15","author":"Lavie","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.08.017_bb0055","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","author":"Ebong","year":"2014","journal-title":"Obes. Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehx750","article-title":"Heart failure subgroups: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation","author":"Luscher","year":"2018","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.yjmcc.2018.08.017_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2018.08.017_bb0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamacardio.2017.2511","article-title":"Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome","volume":"2","author":"Schelbert","year":"2014","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.08.017_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/13543784.14.5.557","article-title":"Agents targeting inflammation in heart failure","volume":"14","author":"Gullestad","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nut.2012.07.003","article-title":"Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions","volume":"29","author":"Deboer","year":"2013","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr. Heart Fail Rep."},{"issue":"7","key":"10.1016\/j.yjmcc.2018.08.017_bb0095","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.117.028145","article-title":"Plasminogen activator inhibitor type I controls cardiomyocyte transforming growth factor-beta and cardiac fibrosis","volume":"136","author":"Flevaris","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.08.017_bb0105","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3892\/etm.2017.4246","article-title":"Transforming growth factor beta and its role in heart disease","volume":"13","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"52","key":"10.1016\/j.yjmcc.2018.08.017_bb0110","doi-asserted-by":"crossref","first-page":"90579","DOI":"10.18632\/oncotarget.21234","article-title":"Interactions between TGF-beta1, canonical WNT\/beta-catenin pathway and PPAR gamma in radiation-induced fibrosis","volume":"8","author":"Vallee","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0115","article-title":"Reduced cardiac fructose 2,6 bisphosphate increases hypertrophy and decreases glycolysis following aortic constriction","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.yjmcc.2018.08.017_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2011.05.009","article-title":"PK-M2 Makes Cells Sweeter on HIF1","volume":"145","author":"Tennant","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cphy.c150016","article-title":"Glucose Transporters in Cardiac Metabolism and Hypertrophy","volume":"6","author":"Shao","year":"2015","journal-title":"Compr. Physiol."},{"issue":"21","key":"10.1016\/j.yjmcc.2018.08.017_bb0130","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity","volume":"119","author":"Yan","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yjmcc.2018.08.017_bb0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cvr\/cvt151","article-title":"Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling","volume":"99","author":"Wei","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2018.08.017_bb0145","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1476-5381.2010.01014.x","article-title":"Cilostazol prevents amyloid beta peptide(25-35)-induced memory impairment and oxidative stress in mice","volume":"161","author":"Hiramatsu","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187872","article-title":"Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease","volume":"12","author":"Chancharoenthana","year":"2017","journal-title":"PLoS ONE"},{"issue":"15\u201316","key":"10.1016\/j.yjmcc.2018.08.017_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.lfs.2009.01.023","article-title":"Cilostazol and pentoxifylline decrease angiogenesis, inflammation, and fibrosis in sponge-induced intraperitoneal adhesion in mice","volume":"84","author":"Mendes","year":"2009","journal-title":"Life Sci."},{"issue":"29","key":"10.1016\/j.yjmcc.2018.08.017_bb0160","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1074\/jbc.M117.779108","article-title":"Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle","volume":"292","author":"Sun","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0165","article-title":"Altered glucose and lipid homeostasis in liver and adipose tissue pre-dispose inducible NOS knockout mice to insulin resistance","volume":"7","author":"Kanuri","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0170","doi-asserted-by":"crossref","first-page":"E2420","DOI":"10.1073\/pnas.1621047114","article-title":"Myocardial aging as a T-cell-mediated phenomenon","volume":"114","author":"Ramos","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.08.017_bb0175","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/HYPERTENSIONAHA.109.147207","article-title":"Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice","volume":"55","author":"Wakui","year":"2010","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.yjmcc.2018.08.017_bb0180","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1161\/01.CIR.0000162506.61443.15","article-title":"Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase","volume":"111","author":"Becker","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1258\/la.2007.06001e","article-title":"Echocardiographic assessment of global left ventricular function in mice","volume":"43","author":"Stypmann","year":"2009","journal-title":"Lab. Anim."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matbio.2017.09.002","article-title":"Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation","volume":"66","author":"Deckx","year":"2018","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.08.017_bb0195","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","article-title":"Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0200","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.115.05548","article-title":"MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis","volume":"66","author":"Wang","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.08.017_bb0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2559.2005.02075.x","article-title":"The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy","volume":"46","author":"Azzawi","year":"2005","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.yjmcc.2018.08.017_bb0210","doi-asserted-by":"crossref","first-page":"F1230","DOI":"10.1152\/ajprenal.00257.2012","article-title":"Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling","volume":"303","author":"Liu","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.taap.2016.08.022","article-title":"Coagulin-L ameliorates TLR4 induced oxidative damage and immune response by regulating mitochondria and NOX-derived ROS","volume":"309","author":"Reddy","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/DMSO.S124541","article-title":"Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity","volume":"10","author":"Karimian","year":"2017","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.022281","article-title":"Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.0000251711.92482.14","article-title":"Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass","volume":"49","author":"Avelar","year":"2007","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.115.06004","article-title":"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin alphaVbeta3\/nuclear factor-kappaB\/interleukin-6 axis","volume":"66","author":"Shimojo","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","article-title":"Glucose metabolism and cardiac hypertrophy","volume":"90","author":"Kolwicz","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/VHRM.S83662","article-title":"Targeting heart failure with preserved ejection fraction: current status and future prospects","volume":"12","author":"Kanwar","year":"2016","journal-title":"Vasc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.yjmcc.2018.08.017_bb0255","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \"fishing expedition\"","volume":"2","author":"Valero-Munoz","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"10","key":"10.1016\/j.yjmcc.2018.08.017_bb0260","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1152\/japplphysiol.00374.2015","article-title":"Myocardial hypertrophy and its role in heart failure with preserved ejection fraction","volume":"119","author":"Heinzel","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5339\/gcsp.2015.3","article-title":"Left ventricular diastolic function and dysfunction: Central role of echocardiography","volume":"2015","author":"Dokainish","year":"2015","journal-title":"Glob. Cardiol. Sci. Pract."},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0270","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"16","key":"10.1016\/j.yjmcc.2018.08.017_bb0275","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurheartj\/ehu067","article-title":"Heart failure with preserved ejection fraction: a clinical dilemma","volume":"35","author":"Komajda","year":"2014","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.yjmcc.2018.08.017_bb0280","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/ATVBAHA.110.221010","article-title":"Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel","volume":"31","author":"Nishioka","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cardfail.2014.11.004","article-title":"Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis","volume":"21","author":"Glezeva","year":"2015","journal-title":"J. Card. Fail."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.08.017_bb0290","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2015.04.110","article-title":"Inflammation in HFpEF: Key or circumstantial?","volume":"189","author":"van Empel","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0300","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.112.112185","article-title":"Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB","volume":"126","author":"Verma","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0305","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2018.08.017_bb0310","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00011-014-0734-4","article-title":"Catechin ameliorates cardiac dysfunction in rats with chronic heart failure by regulating the balance between Th17 and Treg cells","volume":"63","author":"Zhang","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0315","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2008.01.103","article-title":"Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats","volume":"1203","author":"Fujita","year":"2008","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0320","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/FJC.0b013e31829a4e61","article-title":"Heart failure with preserved ejection fraction: emerging drug strategies","volume":"62","author":"Zouein","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0325","doi-asserted-by":"crossref","DOI":"10.21767\/2171-6625.100088","article-title":"Protective role of arginase II in cerebral ischemia and excitotoxicity","volume":"7","author":"Ahmad","year":"2017","journal-title":"J. Neurol. Neurosci."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0330","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","article-title":"Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation","volume":"139","author":"Halade","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.08.017_bb0335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5551\/jat.1685","article-title":"MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation","volume":"17","author":"Kojima","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0340","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jchf.2015.11.013","article-title":"Inflammation in heart failure with preserved ejection fraction: time to put out the fire","volume":"4","author":"Gomberg-Maitland","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0345","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.105.090324","article-title":"Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation","volume":"315","author":"Liu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"55","key":"10.1016\/j.yjmcc.2018.08.017_bb0350","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1038\/sj.onc.1206871","article-title":"Cyclic adenosine 3\u2032,5\u2032-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3\/4-dependent transcription via a protein kinase A-dependent mechanism","volume":"22","author":"Schiller","year":"2003","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.yjmcc.2018.08.017_bb0355","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1074\/jbc.M611871200","article-title":"Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity","volume":"282","author":"Fang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.08.017_bb0360","first-page":"175","article-title":"Beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma","volume":"84","author":"Brabletz","year":"2000","journal-title":"Verh. Dtsch. Ges. Pathol."},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122537","article-title":"Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process","volume":"18","author":"Vallee","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0370","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000369782","article-title":"Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis","volume":"130","author":"Kundu","year":"2015","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.yjmcc.2018.08.017_bb0375","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/cdd.2014.173","article-title":"Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy","volume":"22","author":"Roberts","year":"2015","journal-title":"Cell Death Differ."},{"issue":"28","key":"10.1016\/j.yjmcc.2018.08.017_bb0380","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M115.660498","article-title":"Signaling through the Phosphatidylinositol 3-Kinase (PI3K)\/Mammalian Target of Rapamycin (mTOR) Axis is responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth factor Receptor (EGFR)-mutated Lung Adenocarcinoma","volume":"290","author":"Makinoshima","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.yjmcc.2018.08.017_bb0385","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0390","first-page":"307","article-title":"Cancer morphogenesis: role of mitochondrial failure","volume":"38","author":"Fosslien","year":"2008","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.08.017_bb0395","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2015.02.122","article-title":"A PKM2 signature in the failing heart","volume":"459","author":"Rees","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.yjmcc.2018.08.017_bb0400","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10456-015-9475-4","article-title":"KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma","volume":"18","author":"Ma","year":"2015","journal-title":"Angiogenesis"},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0405","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bbalip.2017.09.009","article-title":"omega-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1alpha and iNOS","volume":"1862","author":"Cheng","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.yjmcc.2018.08.017_bb0410","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1096\/fj.201601291R","article-title":"PHD3 is a transcriptional coactivator of HIF-1alpha in nucleus pulposus cells independent of the PKM2-JMJD5 axis","volume":"31","author":"Schoepflin","year":"2017","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.yjmcc.2018.08.017_bb0415","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.201508-1699ED","article-title":"Aerobic glycolysis and the warburg effect. An unexplored realm in the search for fibrosis therapies?","volume":"192","author":"Maher","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."}],"updated-by":[{"DOI":"10.1016\/j.yjmcc.2019.08.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000}}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818308150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818308150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T04:29:35Z","timestamp":1606192175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818308150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":83,"alternative-id":["S0022282818308150"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.08.017","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.yjmcc.2019.08.012","asserted-by":"object"}]},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}